Our medical products help increase maternal and newborn survival rates, improve mobility, and scale world-class, affordable solutions across more than 70 countries. But don't just take our word for it, see what the numbers say.
Nimble. Our global team can move fast and get great results on modest budgets.
Not-for-profit status. We attract more diverse funding streams and invest in more socially impactful projects than commercial medical companies.
Scalable. Public and private partnerships ensure our products get to market and into the hands of people who need them most.
Impact-driven We rigorously measure our impact, including through third-party evaluations.
Market-driven. We use the market and aim to drive competition, resulting in lower prices, higher quality and interest from other med tech companies.
“This [Brilliance] unit is very good. The results are excellent.”
-Dr. Choudhary, Physician, Bihar, India.
“In 2018, we [Govt. of Rwanda] installed a Brilliance unit in every public hospital with a NICU in Rwanda.”
-Hon. Diane Gashumba, Former Minister of Health, Rwanda.
Independent evaluation of our work.
We actively seek independent, third party monitoring and evaluation.
Our published randomized controlled trial studies
Our third party impact assessments
Our annual reports